HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorenzo Chiariotti Selected Research

D-Aspartate Oxidase

1/2017Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lorenzo Chiariotti Research Topics

Disease

13Neoplasms (Cancer)
06/2022 - 05/2002
5Schizophrenia (Dementia Praecox)
10/2019 - 12/2014
5Thyroid Neoplasms (Thyroid Cancer)
01/2019 - 10/2002
3Glioblastoma (Glioblastoma Multiforme)
06/2022 - 09/2021
3Infections
01/2021 - 02/2011
3Carcinogenesis
09/2009 - 10/2002
2Brain Neoplasms (Brain Tumor)
06/2022 - 01/2022
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 05/2012
2Inflammation (Inflammations)
01/2016 - 10/2002
2Carcinoma (Carcinomatosis)
09/2009 - 10/2002
1Genomic Instability
04/2021
1COVID-19
01/2021
1Fabry Disease (Fabry's Disease)
01/2021
1Polyps
01/2021
1Mental Disorders (Mental Disorder)
10/2019
1Breast Neoplasms (Breast Cancer)
06/2019
1Papillary Thyroid Cancer
06/2019
1Follicular Adenocarcinoma
01/2019
1Chronic Periodontitis
04/2017
1Periodontitis
04/2017
1Pathologic Processes
01/2017
1Crohn Disease (Crohn's Disease)
01/2017
1Hypoxia (Hypoxemia)
01/2016
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
08/2012
1Anaplastic Thyroid Carcinoma
09/2009
1Adenoma (Adenomas)
09/2009
1Neoplastic Cell Transformation
09/2009
1Genetic Translocation (Chromosomal Translocation)
10/2002
1Colonic Neoplasms (Colon Cancer)
10/2002
1Atherosclerosis
10/2002

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
06/2019 - 05/2002
3MethyltransferasesIBA
06/2022 - 06/2019
3Amino AcidsFDA Link
01/2021 - 01/2017
2Alkylating AgentsIBA
06/2022 - 01/2022
2D-Aspartic Acid (D Aspartate)IBA
01/2018 - 01/2017
2Serine (L-Serine)FDA Link
01/2018 - 01/2017
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2016 - 12/2014
2Cadherins (E-Cadherin)IBA
07/2013 - 09/2009
2Transcription Factors (Transcription Factor)IBA
03/2013 - 05/2012
2ChromatinIBA
08/2012 - 02/2011
2Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
11/2004 - 02/2003
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022
1Biomarkers (Surrogate Marker)IBA
06/2022
1hydrogen sulfite (bisulfite)IBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1CateninsIBA
09/2021
1Genetic Markers (Genetic Marker)IBA
04/2021
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1globotriaosylceramide (globotriosylceramide)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Phosphates (Orthophosphate)IBA
01/2021
1PolymersIBA
01/2021
1PolyphosphatesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Viral RNAIBA
01/2021
1Viral Structural Proteins (VP(1))IBA
01/2021
1CytokinesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
06/2019
1Long Noncoding RNAIBA
06/2019
1RacivirIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2018
116S Ribosomal RNAIBA
04/2017
1DefensinsIBA
01/2017
1D-Aspartate OxidaseIBA
01/2017
1A-factor (Streptomyces)IBA
01/2017
1Aspartic Acid (Aspartate)FDA Link
01/2017
1EnzymesIBA
01/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017
1serine racemaseIBA
01/2017
1LipopolysaccharidesIBA
01/2016
1Galectin 3 (LGALS3)IBA
07/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2013
1Ubiquitin-Conjugating EnzymesIBA
03/2013
1UbiquitinIBA
03/2013
1Methyl-CpG-Binding Protein 2IBA
08/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2012
1Histone Deacetylase 2IBA
09/2009
1Tyrosine (L-Tyrosine)FDA Link
11/2004
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
11/2004
1Complementary DNA (cDNA)IBA
02/2003
1PPAR-gamma AgonistsIBA
10/2002
1PPAR gammaIBA
10/2002
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2002

Therapy/Procedure

4Therapeutics
06/2022 - 10/2002
1Investigational Therapies (Experimental Therapy)
10/2002